MedPath

Comparison of two drugs in post operative pain management in breast surgeries

Not Applicable
Conditions
Health Condition 1: - Health Condition 2: R20-R23- Symptoms and signs involving the skin and subcutaneous tissue
Registration Number
CTRI/2019/12/022389
Lead Sponsor
Vijayanagar institute of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA physical status I & II patients

Female patients in the age group of 18 to 65 years.

Patients posted for elective unilateral breast surgeries with or without axillary clearance under general anaesthesia.

Exclusion Criteria

Refusal by patients for the block.

Surgery duration more than 2 hours.

History of significant systemic disorders (cardiovascular, respiratory,

central nervous system or renal system).

Infection at block site of block.

Thoracic wall and chest wall deformities.

Allergy to the study drugs.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the duration of postoperative analgesiaTimepoint: Study parameters are observed and recorded just before the administration of block, 5 minutes after administration, at the time of skin incision and every 10 minutes intra-operatively following the block till extubation and post-operatively at 5 min, 15min, 30min, then hourly for first 2 hours and at 4,6,12,24hrs after extubation. Post-operative pain will be assessed using visual analog scale (VAS) at rest and at coughing. Inj.tramadol 50 mg IV is used as rescue analgesic when VAS score is 4.
Secondary Outcome Measures
NameTimeMethod
the need for rescue analgesic, <br/ ><br>total dose of rescue analgesic required, <br/ ><br>perioperative haemodynamics <br/ ><br>incidence of post-operative nausea and vomiting (PONV) and <br/ ><br>adverse effects, if any.Timepoint: Up to 24hrs after extubation
© Copyright 2025. All Rights Reserved by MedPath